Literature DB >> 24742244

S100A4 is an independent prognostic factor for patients with lung cancer: a meta-analysis.

Hao Bai1, Jia-Lin Qian, Bao-Hui Han.   

Abstract

OBJECTIVE: To evaluate the association of S100A4 levels with the prognosis of lung cancer (LC).
METHODS: The RevMan 5.0 software was utilized to perform literature retrieval, data collection, and statistical analysis according to its guidelines. Literature-based searching was guided to gather data, and the fixed-effect model was used to pool the hazard ratio (HR) in this study.
RESULTS: A total of 10 eligible studies that included 1364 LC patients were analyzed. About 72.6% of patients had positive expression of S100A4 according to the criteria defined by the authors. The HR of positive expression for overall survival (OS) was 1.30 times of that of negative expression in LC patients (HR=1.30, 95% confidence interval: 1.04 to 1.61, p=0.02).
CONCLUSION: Patients with positive expression of S100A4 appear to have a poorer OS compared with those with negative expression of S100A4.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24742244     DOI: 10.1089/gtmb.2013.0471

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  3 in total

1.  Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.

Authors:  Wang Yan; Jiaqi Chen; Zhaoying Chen; Huimin Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 2.  Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis.

Authors:  Shanshan Huang; Jiawei Zheng; Yufang Huang; Li Song; Yin Yin; Danzhen Ou; Shangxiang He; Xiong Chen; Xuenong Ouyang
Journal:  Dis Markers       Date:  2016-01-19       Impact factor: 3.434

3.  Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.

Authors:  Jing Zhang; Yanhui Gu; Xiaoli Liu; Ximin Rao; Guichuan Huang; Yao Ouyang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.